ETF Holdings Breakdown of IRWD

IRWD institutional holdings

The adjusted close for IRWD on 2025-11-11 was 2.89

The following institutional investment holdings of IRWD have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-11	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	98,188 0.3%	USD 283,763 12.7%	2.89
2025-11-11	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	98,188 0.3%	USD 283,763 12.7%	2.89
Total =		196,376	USD 567,526

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with IRWD

Ironwood Pharmaceuticals (NASDAQ:IRWD) & Reviva Pharmaceuticals (NASDAQ:RVPH) Critical Comparison

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation. Insider and Institutional Ownership 63.2% of Reviva […] - 2025-09-11 04:46:30

Pacer Advisors Inc. Sells 9,941,673 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Pacer Advisors Inc. reduced its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 84.7% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,789,098 shares of the biotechnology company’s stock after selling 9,941,673 shares during the period. Pacer Advisors Inc.’s holdings in Ironwood Pharmaceuticals were worth $2,630,000 as of its […] - 2025-07-30 05:36:49

Cerity Partners LLC Buys New Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Cerity Partners LLC bought a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) in the first quarter, HoldingsChannel.com reports. The institutional investor bought 96,478 shares of the biotechnology company’s stock, valued at approximately $142,000. Other large investors also recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. […] - 2025-07-30 04:44:43

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) have been assigned an average rating of “Hold” from the eight brokerages that are covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 […] - 2025-07-25 05:14:52

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 286,990 shares of the biotechnology company’s stock after purchasing an additional […] - 2025-06-10 04:29:01

Two Sigma Investments LP Lowers Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Two Sigma Investments LP reduced its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 3.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 863,428 shares of the biotechnology company’s stock after selling 27,535 shares during the period. Two Sigma Investments LP’s holdings in Ironwood Pharmaceuticals were worth $3,825,000 as of its […] - 2025-05-29 05:12:56

Comerica Bank Sells 28,108 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Comerica Bank lessened its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 18.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,083 shares of the biotechnology company’s stock after selling 28,108 shares during the period. Comerica Bank owned […] - 2025-05-15 04:52:50

Tower Research Capital LLC TRC Boosts Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Tower Research Capital LLC TRC increased its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 1,130.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,521 shares of the biotechnology company’s stock after buying an additional 16,097 shares during the quarter. […] - 2025-05-11 06:36:52

XTX Topco Ltd Invests $203,000 in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

XTX Topco Ltd bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 45,881 shares of the biotechnology company’s stock, valued at approximately $203,000. Other institutional investors have also recently modified their holdings of the company. Journey Strategic Wealth LLC purchased a new stake […] - 2025-04-28 05:11:01

Ironwood Raises 2025 Adj. EBITDA Outlook

(RTTNews) - Ironwood Pharmaceuticals (IRWD) reiterated full year 2025 LINZESS U.S. net sales and total Ironwood revenue guidance and increased adjusted EBITDA guidance. The company has raised full-year 2025 adjusted EBITDA guidance to greater than $105 million as it no longer pla - 2025-04-25 08:22:36

Federated Hermes Inc. Makes New Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Federated Hermes Inc. purchased a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 370,476 shares of the biotechnology company’s stock, valued at approximately $1,641,000. Federated Hermes Inc. owned […] - 2025-04-15 04:54:50

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $8.60 Consensus Price Target from Brokerages

Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month […] - 2025-04-14 03:01:00

Intech Investment Management LLC Acquires 13,205 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Intech Investment Management LLC boosted its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 30.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,244 shares of the biotechnology company’s stock after buying an additional 13,205 shares during the quarter. Intech Investment […] - 2025-03-27 06:28:55

15,147 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 15,147 shares of the biotechnology company’s stock, valued at approximately $67,000. A number of other institutional investors also recently bought and sold shares of IRWD. Pacer Advisors […] - 2025-03-06 08:44:39

Back to Listing

Disclaimer